CHA₂DS₂-VASc Score Calculator
Estimate stroke risk in nonvalvular atrial fibrillation from clinical risk factors.
- Age 65–74+1
Not a treatment decision on its own. Anticoagulation decisions weigh stroke risk against bleeding risk (commonly assessed with a score like HAS-BLED) and patient preference. A score of 1 in a woman with no other risk factors is generally not considered sufficient reason for anticoagulation on its own. Discuss results with a healthcare provider.
How the score is built
| Criterion | Points |
|---|---|
| Congestive heart failure / LV dysfunction | 1 |
| Hypertension | 1 |
| Age ≥ 75 | 2 |
| Diabetes mellitus | 1 |
| Stroke, TIA, or thromboembolism (prior) | 2 |
| Vascular disease (MI, PAD, aortic plaque) | 1 |
| Age 65–74 | 1 |
| Sex category female | 1 |
Maximum score: 9.
Annual stroke risk by score
| Score | Approx. annual stroke risk |
|---|---|
| 0 | 0% |
| 1 | 1.3% |
| 2 | 2.2% |
| 3 | 3.2% |
| 4 | 4.0% |
| 5 | 6.7% |
| 6 | 9.8% |
| 7 | 9.6% |
| 8 | 6.7% |
| 9 | 15.2% |
Source: Friberg L, et al. Eur Heart J. 2012;33(12):1500-10. A large registry cohort — other studies report somewhat different absolute rates, and scores of 7–8 show non-monotonic results due to smaller sample sizes at those levels in this dataset.
Common questions
It estimates the risk of ischemic stroke in people with nonvalvular atrial fibrillation, and is used alongside a bleeding-risk assessment to help decide whether anticoagulation is likely to provide net benefit.